Detalles de la búsqueda
1.
Linked Patient-Reported Outcomes Data From Patients With Multiple Sclerosis Recruited on an Open Internet Platform to Health Care Claims Databases Identifies a Representative Population for Real-Life Data Analysis in Multiple Sclerosis.
J Med Internet Res
; 18(9): e249, 2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658498
2.
Medical care costs and survival associated with hepatocellular carcinoma among the elderly.
Clin Gastroenterol Hepatol
; 10(5): 547-54, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210536
3.
Incidence of venous thromboembolism among chemotherapy-treated patients with lung cancer and its association with mortality: a retrospective database study.
J Thromb Thrombolysis
; 34(4): 446-56, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22581282
4.
Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.
J Manag Care Pharm
; 16(4): 264-75, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20433217
5.
Lifetime and treatment-phase costs associated with colorectal cancer: evidence from SEER-Medicare data.
Clin Gastroenterol Hepatol
; 7(2): 198-204, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18849013
6.
Factors associated with improved survival among older colorectal cancer patients in the US: a population-based analysis.
BMC Cancer
; 9: 227, 2009 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-19594933
7.
Trends in healthcare utilization among older Americans with colorectal cancer: a retrospective database analysis.
BMC Health Serv Res
; 9: 227, 2009 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-20003294
8.
Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study.
Mult Scler Relat Disord
; 27: 65-73, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342416
9.
Establishing pathological cut-offs for lateral ventricular volume expansion rates.
Neuroimage Clin
; 18: 494-501, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29527505
10.
Assessing 'No Evidence of Disease Activity' Status in Patients with Relapsing-Remitting Multiple Sclerosis Receiving Fingolimod in Routine Clinical Practice: A Retrospective Analysis of the Multiple Sclerosis Clinical and Magnetic Resonance Imaging Outcomes in the USA (MS-MRIUS) Study.
CNS Drugs
; 32(1): 75-84, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29270772
11.
No evidence of disease activity in patients receiving fingolimod at private or academic centers in clinical practice: a retrospective analysis of the multiple sclerosis, clinical, and magnetic resonance imaging outcomes in the USA (MS-MRIUS) study.
Curr Med Res Opin
; 34(8): 1431-1440, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29648900
12.
Fingolimod's Impact on MRI Brain Volume Measures in Multiple Sclerosis: Results from MS-MRIUS.
J Neuroimaging
; 28(4): 399-405, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29749661
13.
Angioedema Among Hypertensive Patients Treated with Aliskiren or Other Antihypertensive Medications in the United States.
Am J Cardiovasc Drugs
; 17(6): 465-474, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28779444
14.
An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.
J Neuroimaging
; 27(3): 339-347, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27918139
15.
Expanding the use of administrative claims databases in conducting clinical real-world evidence studies in multiple sclerosis.
Curr Med Res Opin
; 31(5): 1029-39, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25661016
16.
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Curr Med Res Opin
; 30(8): 1461-71, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754349
17.
Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.
PLoS One
; 9(2): e88472, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24516663
18.
Estimating effectiveness and cost of biologics for rheumatoid arthritis: application of a validated algorithm to commercial insurance claims.
Clin Ther
; 36(7): 996-1004, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25012729
19.
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
J Med Econ
; 17(10): 696-707, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25019581
20.
Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis.
J Med Econ
; 17(8): 555-66, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24754646